136 related articles for article (PubMed ID: 12799526)
1. Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice.
Popik P; Wrobel M; Rygula R; Bisaga A; Bespalov AY
Behav Pharmacol; 2003 May; 14(3):237-44. PubMed ID: 12799526
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists.
Blokhina EA; Sukhotina IA; Bespalov AY
Eur J Pharmacol; 2000 Oct; 406(2):227-32. PubMed ID: 11020485
[TBL] [Abstract][Full Text] [Related]
3. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine.
Popik P; Danysz W
J Pharmacol Exp Ther; 1997 Feb; 280(2):854-65. PubMed ID: 9023300
[TBL] [Abstract][Full Text] [Related]
5. The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats.
Ma YY; Guo CY; Yu P; Lee DY; Han JS; Cui CL
Exp Neurol; 2006 Aug; 200(2):343-55. PubMed ID: 16631172
[TBL] [Abstract][Full Text] [Related]
6. Memantine blocks sensitization to the rewarding effects of morphine.
Aguilar MA; Manzanedo C; Do Couto BR; Rodríguez-Arias M; Miñarro J
Brain Res; 2009 Sep; 1288():95-104. PubMed ID: 19596276
[TBL] [Abstract][Full Text] [Related]
7. Morphine-induced place preference: involvement of the central amygdala NMDA receptors.
Rezayof A; Golhasani-Keshtan F; Haeri-Rohani A; Zarrindast MR
Brain Res; 2007 Feb; 1133(1):34-41. PubMed ID: 17184750
[TBL] [Abstract][Full Text] [Related]
8. Memantine does not block antiaggressive effects of morphine in mice.
Rodríguez-Arias M; Maldonado C; Aguilar MA; Miñarro J
Behav Pharmacol; 2002 May; 13(3):249-52. PubMed ID: 12122316
[TBL] [Abstract][Full Text] [Related]
9. NMDA receptors of dorsal hippocampus are involved in the acquisition, but not in the expression of morphine-induced place preference.
Zarrindast MR; Lashgari R; Rezayof A; Motamedi F; Nazari-Serenjeh F
Eur J Pharmacol; 2007 Jul; 568(1-3):192-8. PubMed ID: 17509561
[TBL] [Abstract][Full Text] [Related]
10. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice.
Popik P; Kozela E; Danysz W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
Kozela E; Pilc A; Popik P
Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
[TBL] [Abstract][Full Text] [Related]
12. Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice.
Belozertseva IV; Bespalov AYu
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):270-4. PubMed ID: 9750014
[TBL] [Abstract][Full Text] [Related]
13. Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA.
García-Pardo MP; Escobar-Valero C; Rodríguez-Arias M; Miñarro J; Aguilar MA
Behav Pharmacol; 2015 Aug; 26(5):411-7. PubMed ID: 25974188
[TBL] [Abstract][Full Text] [Related]
14. Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA-receptor antagonist.
Papp M; Gruca P; Willner P
Neuropsychopharmacology; 2002 Nov; 27(5):727-43. PubMed ID: 12431848
[TBL] [Abstract][Full Text] [Related]
15. Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal.
Maldonado C; Cauli O; Rodríguez-Arias M; Aguilar MA; Miñarro J
Behav Brain Res; 2003 Sep; 144(1-2):25-35. PubMed ID: 12946592
[TBL] [Abstract][Full Text] [Related]
16. Reinstatement of morphine-conditioned reward is blocked by memantine.
Popik P; Wrobel M; Bisaga A
Neuropsychopharmacology; 2006 Jan; 31(1):160-70. PubMed ID: 15886718
[TBL] [Abstract][Full Text] [Related]
17. Effects of the non-competitive NMDA receptor antagonist ifenprodil on the morphine-induced place preference in mice.
Suzuki T; Kato H; Tsuda M; Suzuki H; Misawa M
Life Sci; 1999; 64(12):PL151-6. PubMed ID: 10210291
[TBL] [Abstract][Full Text] [Related]
18. Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test.
Popik P; Kozela E
Pol J Pharmacol; 1999; 51(3):223-31. PubMed ID: 10600036
[TBL] [Abstract][Full Text] [Related]
19. Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats.
Bespalov AY; Dravolina OA; Zvartau EE; Beardsley PM; Balster RL
Eur J Pharmacol; 2000 Mar; 390(3):303-11. PubMed ID: 10708738
[TBL] [Abstract][Full Text] [Related]
20. The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.
Popik P; Skolnick P
Pharmacol Biochem Behav; 1996 Apr; 53(4):791-7. PubMed ID: 8801580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
